Literature DB >> 10425362

Proniosomes: a novel drug carrier preparation.

C Hu1, D G Rhodes.   

Abstract

A procedure is described for producing a dry product which may be hydrated immediately before use to yield aqueous niosome dispersions similar to those produced by more cumbersome conventional methods. These 'proniosomes' minimize problems of niosome physical stability such as aggregation, fusion and leaking, and provide additional convenience in transportation, distribution, storage, and dosing. This report describes the preparation of dispersions of proniosome-derived niosomes, comparison of these niosomes to conventional niosomes, and optimization of proniosome formulations. In addition, conventional and proniosome-derived niosomes are compared in terms of their morphology, particle size, particle size distribution, and drug release performance in synthetic gastric or intestinal fluid. In all comparisons, proniosome-derived niosomes are as good or better than conventional niosomes.

Mesh:

Substances:

Year:  1999        PMID: 10425362     DOI: 10.1016/s0378-5173(99)00122-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  25 in total

1.  SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes.

Authors:  A I Blazek-Welsh; D G Rhodes
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

3.  Enhanced oral bioavailability of griseofulvin via niosomes.

Authors:  Pratap S Jadon; Virendra Gajbhiye; Rajesh S Jadon; Kavita R Gajbhiye; Narayanan Ganesh
Journal:  AAPS PharmSciTech       Date:  2009-10-24       Impact factor: 3.246

4.  Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.

Authors:  Pinakin Sukthankar; L Adriana Avila; Susan K Whitaker; Takeo Iwamoto; Alfred Morgenstern; Christos Apostolidis; Ke Liu; Robert P Hanzlik; Ekaterina Dadachova; John M Tomich
Journal:  Biochim Biophys Acta       Date:  2014-02-22

5.  Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.

Authors:  Tamer M Shehata; Marwa H Abdallah; Mahmoud Mokhtar Ibrahim
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

Review 6.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

7.  Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.

Authors:  Anahita Fathi-Azarbayjani; Kai Xin Ng; Yew Weng Chan; Sui Yung Chan
Journal:  Adv Pharm Bull       Date:  2015-03-05

8.  Maltodextrin-based proniosomes.

Authors:  A I Blazek-Welsh; D G Rhodes
Journal:  AAPS PharmSci       Date:  2001

9.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

10.  Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes.

Authors:  Varaporn Buraphacheep Junyaprasert; Veerawat Teeranachaideekul; Tasaneeya Supaperm
Journal:  AAPS PharmSciTech       Date:  2008-07-18       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.